News
Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): Results of an a priori interim analysis of a multicenter phase I trial. This is an ASCO Meeting Abstract from the 2022 ASCO ...
Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback